// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Atrial fibrillation ablation as a day-case procedure: three-year single-centre experience

S Bartoletti - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Protamine Sulfate

Derivation of a prediction model for the optimization of patient selection for catheter ablation of atrial fibrillation: the AF-FREEDOM score.

Rui Providencia - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Multimodality image reconstruction and fusion to guide VT ablation

NF Kelland - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Development of atrial fibrillation following ablation for typical atrial flutter cannot be predicted by conventional risk factors; time for a rethink in ablation strategy?

M Mann - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Ablation of longstanding persistent atrial fibrillation using the ACQMAP 3-D mapping system – an early single centre experience

E Shepherd - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Improving target identification of persistent atrial fibrillation ablation using simultaneous intracardiac mapping

Xin Li - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Accuracy of left atrial bipolar voltages obtained by ConfiDENSE multielectrode mapping in patients with persistent atrial fibrillation

B Maille - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Power, lesion size index and oesophageal temperature alerts during atrial fibrillation ablation (PILOT-AF): a randomized study

M. Leo - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Application of the novel ‘shanghai’ diagnostic criteria for brugada syndrome reduces the number of diagnoses with low risk of arrhythmic events in index cases

G Mellor - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Flecainide

Evolution of PROMS data and what it tells us about patients undergoing catheter ablation for atrial fibrillation

J Girach - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

A profile of a UK paediatric population with postural tachycardia syndrome

LA Kavi - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Not narrow, not wide: a 15 year old with recurrent episodes of tachyarrhythmia

R Fortner - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Amiodarone Hydrochloride

Can high volume tertiary centres with 24/7 device implanting service provide improved efficacy and outcomes compared to a large district general hospital model?

N Karim - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does non-specialist care mean under treatment with antiarrhythmic drugs and poor DC cardioversion outcome for persistent atrial fibrillation - a single centre study

C Broughton - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Identifying opportunities to prevent AF-related stroke through better access to NHS primary and secondary care data

J Macdonald - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Predicting success of atrial fibrillation ablation by point by point and single shot ablation techniques

TA Nelson - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Long term outcome following left atrial appendage occlusion: real world experience from a single centre prospective registry

R Ang - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Use of ECGi and re-entry vulnerability index to predict VT Re-entry sites in sinus rhythm

A.J. Graham - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Sotalol

Impact of QTc formulae in the prevalence of short and long corrected QT intervals in a young adult cohort

Rui Providencia - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Routine pre assessment variables fail to predict response to CRT

L Carlisle - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved